Delivery Order SPE2DR25D3303-SPE2DR26F63F7
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,027.27 to AmerisourceBergen Drug Corp for Pyridostigmine Bromide 60 mg tablets (30-count) on December 9, 2025, with completion scheduled for December 10, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Pyridostigmine bromide is a cholinesterase inhibitor commonly used to treat...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Pyridostigmine Bromide 60 mg tablets (30-count units) with a ceiling value of $1,142.40. The contract utilizes firm fixed price terms and carries an ultimate completion date of July 1, 2025. This non-set-aside, competitively awarded delivery order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Pyridostigmine Bromide 30 mg tablets on December 5, 2025, with a ceiling value of $2,221.66 and an ultimate completion date of December 8, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Pyridostigmine bromide is a pharmaceutical used primarily in the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Pyridostigmine Bromide 30 mg tablets, with a ceiling value of $1,810.85. The award, issued on May 30, 2025, with an ultimate completion date of June 2, 2025, represents a firm fixed-price delivery order with no set-aside designation. Performance will be executed from the contractor's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency awarded a delivery order valued at $2,705.32 to AmerisourceBergen Drug Corp for the supply of Pyridostigmine Bromide 30 mg tablets (UU 21S) on August 19, 2025, with an ultimate completion date of August 20, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Pyridostigmine Bromide 60 mg tablets in quantities of 30. This competitively awarded, non-set-aside contract carries a ceiling value of $1,090.09 and has an ultimate completion date of September 26, 2025. The contract utilizes firm fixed price terms and represents a delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on October 22, 2025, for Pyridostigmine Bromide 30 mg tablets. This firm fixed-price delivery order, valued at $3,237.97, represents a non-competitive set-aside award with an ultimate completion date of October 23, 2025. The contract will be performed at the contractor's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Pyridostigmine Bromide 60 mg tablets (30-count packages) on September 5, 2025, with a ceiling value of $2,051.45 and ultimate completion date of September 8, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded through open competition. The pharmaceutical product will be performed at AmerisourceBergen Drug Corp's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $14,166.32 to AmerisourceBergen Drug Corp for the supply of Pyridostigmine Bromide 30 mg tablets with an ultimate completion date of September 19, 2025. This is a firm fixed-price delivery order under a competitively awarded, non-set-aside contract. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly...
- The Defense Logistics Agency awarded a delivery order valued at $3,328.30 to AmerisourceBergen Drug Corp for the supply of Pyridostigmine Bromide 30 mg tablets, with an ultimate completion date of December 1, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly...
- SPE2DR25D3303Indefinite Delivery Contract
- SPE2DR25D3303-SPE2DR26F63F7Delivery Order
The Defense Logistics Agency awarded a $1,539.82 delivery order to AmerisourceBergen Drug Corp for the supply of Pyridostigmine Bromide 60 mg tablets in quantities of 30 units. This firm fixed price delivery order, issued on December 9, 2025, with a completion date of December 10, 2025, represents a non-set-aside competitive award to support federal pharmaceutical procurement needs. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a wide range of medications, vaccines, and medical supplies to support military healthcare programs. Pyridostigmine bromide is an acetylcholinesterase inhibitor used in military medicine and veteran healthcare for conditions including myasthenia gravis, and this delivery order fulfills immediate pharmaceutical supply requirements within the broader DLA medical supply chain supporting the Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 12/8/25 |